A strain belonging to subfamily coronavirinae in the family coronaviridae of the order Nidovirales and they are classified as SARS-like species.
Published in Chapter:
Quercetin for the Experimental Treatment of COVID-19
Kunal Bhattacharya (NETES Institute of Pharmaceutical Science, India), Nongmaithem Randhoni Chanu (FPS, Assam Downtown University, India), Atanu Bhattacharjee (Royal School of Pharmacy, The Assam Royal Global University, India), Ripunjoy Bordoloi (NETES Institute of Pharmaceutical Science, India), Bhargab Jyoti Sahariah (NETES Institute of Pharmaceutical Science, India), Apurba Talukdar (NETES Institute of Pharmaceutical Science, India), and Ramen Kalita (NETES Institute of Pharmaceutical Science, India)
Copyright: © 2021
|Pages: 19
DOI: 10.4018/978-1-7998-7258-0.ch004
Abstract
The pandemic, which is brought about by the SARS CoV-2 infection, has inundated the entire world and obliterated the economies of numerous nations. Hence, looking for treatment and prophylaxis of COVID-19, Quercetin, which is a flavonoid gotten from plants and different sources like grapes, onion, tomatoes, apple, and so forth and has various properties like calming property, cardioprotective, and neuroprotective properties, is inspected for its antiviral properties, so it tends to be considered as one of the adjuvant medicines alongside the pharmacological medicines like Remdesivir and plasma treatment. A survey of the antiviral property of Quercetin from distributed articles proposes that Quercetin has a solid antiviral movement towards SARS C0V-2 and other upper respiratory tract infections. It can be securely and financially used to battle COVID-19. For high-hazard populaces, this medication can be a brilliant decision of treatment. Here the authors give proof to the utilization of Quercetin in relationship with pharmacological treatments like Remdesivir or improving plasma treatment.